In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Medical device company Tactile Systems Technology nets $38.3mm in IPO

Executive Summary

Tactile Systems Technology Inc. (pneumatic compression devices) netted $38.3mm in its Nasdaq IPO of 4.12mm shares (slightly up-sized from 4mm shares at time of filing) at $10 (well below the expected $14-16 per share range). Proceeds will be used to expand sales, marketing, reimbursement, clinical, regulatory and product development activities, and a portion will also go to pay the cumulative accrued dividends of Series A preferred stockholders.
Deal Industry
  • Medical Devices
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies